GlassScriptPhysician profile
Whitney C Jackson
NPI 1518508282
$2,523.89
in general payments reported to CMS, 2019-2025
31 companies · $474 in 2025
The $474 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $82.88 · 2022: $685 · 2023: $675 · 2024: $606 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,755.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $370.50 | 2022-2024 | |
| Abbvie INC. | $306.63 | 2022-2025 | |
| Medtronic, INC. | $288.46 | 2022-2025 | Inceptiv, Synchromedii, Intellis Adaptivestim |
| Tersera Therapeutics LLC | $197.05 | 2022-2025 | Prialt |
| Merz Pharmaceuticals, LLC | $141.34 | 2023-2024 | Xeomin |
| Collegium Pharmaceutical, INC. | $117.49 | 2023-2025 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $112.82 | 2022-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $97.00 | 2021-2023 | Ztlido |
| Mission Medical Distribution, LLC | $85.65 | 2023 | |
| Painteq LLC | $81.72 | 2023-2024 | Painteq |
| Pfizer INC. | $72.50 | 2021-2023 | |
| Bioventus LLC | $71.70 | 2022-2025 | Xcell |
| Azurity Pharmaceuticals, INC. | $68.55 | 2023-2024 | Horizant, Horizant |
| Grt US Holding, INC. | $60.19 | 2022 | |
| Ibsa Pharma INC. | $60.09 | 2022-2024 | Tirosint, Licart, Licart |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $41.52 | 2023 | Qutenza |
| Piramal Critical Care | $39.29 | 2024-2025 | |
| Spr Therapeutics, INC | $36.65 | 2025 | Sprint Pns System |
| Valinor Pharma, LLC | $32.91 | 2025 | Movantik |
| Globus Medical, INC. | $30.76 | 2025 | Senza |
| Relievant Medsystems, INC. | $29.24 | 2022-2023 | Intracept |
| Depuy Synthes Sales INC. | $25.93 | 2025 | Orthovisc, Monovisc |
| Fidia Pharma USA INC. | $22.00 | 2023 | Hymovis, Triluron |
| Teva Pharmaceuticals USA, INC. | $20.93 | 2023 | Ajovy |
| Boston Scientific Corporation | $19.59 | 2025 | Wavewriter Alpha Prime 16 |
| Kowa Pharmaceuticals America, INC. | $16.66 | 2022 | |
| Tris Pharma INC | $16.01 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.00 | 2024 | |
| Almatica Pharma LLC | $15.82 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.41 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.